Do These 3 Healthcare Stocks Need a Checkup?

These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk?The pharmaceutical industry is highly competitive, and currently, the leading company in the sector is likely Eli Lilly (LLY 0.41%). That's driven by the fact that Eli Lilly makes the weight loss drugs Zepbound and Mounjaro, which together account for over 50% of the company's revenue. That's an interesting statistic because it highlights both the risk and opportunity that exists in the drug sector.If you own o ...